Bio-Path Holdings, Inc.

BPTH · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$9,894-$16,078-$13,868-$10,440
Dep. & Amort.$159$178$178$161
Deferred Tax$0$0-$507-$1,342
Stock-Based Comp.$566$734$851$821
Change in WC$678$3,133-$2,264-$459
Other Non-Cash-$2,084$498$507$1,342
Operating Cash Flow-$10,575-$11,535-$15,103-$9,917
Investing Activities
PP&E Inv.$0$0-$21-$70
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0-$21-$70
Investing Cash Flow$0$0-$21-$70
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$10,696$1,677$1,734$15,849
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$526$0$4,157
Financing Cash Flow$10,696$2,203$1,734$20,006
Forex Effect$0$0$0$0
Net Chg. in Cash$121-$9,332-$13,390$10,019
Supplemental Information
Beg. Cash$1,052$10,384$23,774$13,755
End Cash$1,173$1,052$10,384$23,774
Free Cash Flow-$10,575-$11,535-$15,124-$9,987
Bio-Path Holdings, Inc. (BPTH) Financial Statements & Key Stats | AlphaPilot